Supplementary Table 3 from Synthetic Lethal Targeting of <i>ARID1A</i>-Mutant Ovarian Clear Cell Tumors with Dasatinib

Abstract

&lt;p&gt;Additional compounds included in the isogenic high-throughput drug screen&lt;/p&gt;